BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16258329)

  • 1. Stability of transmitted drug-resistant HIV-1 species.
    Cane PA
    Curr Opin Infect Dis; 2005 Dec; 18(6):537-42. PubMed ID: 16258329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 drug resistance in newly infected individuals.
    Boden D; Hurley A; Zhang L; Cao Y; Guo Y; Jones E; Tsay J; Ip J; Farthing C; Limoli K; Parkin N; Markowitz M
    JAMA; 1999 Sep 22-29; 282(12):1135-41. PubMed ID: 10501116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
    Little SJ; Daar ES; D'Aquila RT; Keiser PH; Connick E; Whitcomb JM; Hellmann NS; Petropoulos CJ; Sutton L; Pitt JA; Rosenberg ES; Koup RA; Walker BD; Richman DD
    JAMA; 1999 Sep 22-29; 282(12):1142-9. PubMed ID: 10501117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France.
    Chaix ML; Descamps D; Wirden M; Bocket L; Delaugerre C; Tamalet C; Schneider V; Izopet J; Masquelier B; Rouzioux C; Meyer L; Costagliola D; ; ;
    AIDS; 2009 Mar; 23(6):717-24. PubMed ID: 19279445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.
    Shafer RW; Rhee SY; Pillay D; Miller V; Sandstrom P; Schapiro JM; Kuritzkes DR; Bennett D
    AIDS; 2007 Jan; 21(2):215-23. PubMed ID: 17197813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV transmitted drug resistance in adult and pediatric populations in Panama.
    Castillo J; Arteaga G; Mendoza Y; Martínez AA; Samaniego R; Estripeaut D; Page KR; Smith RE; Sosa N; Pascale JM
    Rev Panam Salud Publica; 2011 Dec; 30(6):649-56. PubMed ID: 22358417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time trends in primary HIV-1 drug resistance among recently infected persons.
    Grant RM; Hecht FM; Warmerdam M; Liu L; Liegler T; Petropoulos CJ; Hellmann NS; Chesney M; Busch MP; Kahn JO
    JAMA; 2002 Jul; 288(2):181-8. PubMed ID: 12095382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2019 update of the drug resistance mutations in HIV-1.
    Wensing AM; Calvez V; Ceccherini-Silberstein F; Charpentier C; Günthard HF; Paredes R; Shafer RW; Richman DD
    Top Antivir Med; 2019 Sep; 27(3):111-121. PubMed ID: 31634862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.
    Gallego O; Ruiz L; Vallejo A; Ferrer E; Rubio A; Clotet B; Leal M; Soriano V;
    AIDS; 2001 Sep; 15(14):1894-6. PubMed ID: 11579258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1: case report and response to raltegravir-containing antiretroviral therapy.
    Young B; Fransen S; Greenberg KS; Thomas A; Martens S; St Clair M; Petropoulos CJ; Ha B
    Antivir Ther; 2011; 16(2):253-6. PubMed ID: 21447875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals.
    Simon V; Vanderhoeven J; Hurley A; Ramratnam B; Louie M; Dawson K; Parkin N; Boden D; Markowitz M
    AIDS; 2002 Jul; 16(11):1511-9. PubMed ID: 12131189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece.
    Paraskevis D; Magiorkinis E; Katsoulidou A; Hatzitheodorou E; Antoniadou A; Papadopoulos A; Poulakou G; Paparizos V; Botsi C; Stavrianeas N; Lelekis M; Chini M; Gargalianos P; Magafas N; Lazanas M; Chryssos G; Petrikkos G; Panos G; Kordossis T; Theodoridou M; Sypsa V; Hatzakis A;
    Virus Res; 2005 Sep; 112(1-2):115-22. PubMed ID: 16022906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of triple-class, drug-resistant HIV-1 in Australia.
    Tong WW; McAllister J; White PA; Kelleher AD; Carr A
    Intern Med J; 2010 Sep; 40(9):657-61. PubMed ID: 20862783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients.
    Birk M; Sönnerborg A
    AIDS; 1998 Dec; 12(18):2369-75. PubMed ID: 9875574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.
    Salomon H; Wainberg MA; Brenner B; Quan Y; Rouleau D; Coté P; LeBlanc R; Lefebvre E; Spira B; Tsoukas C; Sekaly RP; Conway B; Mayers D; Routy JP
    AIDS; 2000 Jan; 14(2):F17-23. PubMed ID: 10708278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evolution of HIV resistance mutations in the Valme referral center].
    Nogales MC; Castro C; Martín-Mazuelos E
    Enferm Infecc Microbiol Clin; 2007 Feb; 25(2):159. PubMed ID: 17288915
    [No Abstract]   [Full Text] [Related]  

  • 17. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.
    Descamps D; Chaix ML; Montes B; Pakianather S; Charpentier C; Storto A; Barin F; Dos Santos G; Krivine A; Delaugerre C; Izopet J; Marcelin AG; Maillard A; Morand-Joubert L; Pallier C; Plantier JC; Tamalet C; Cottalorda J; Desbois D; Calvez V; Brun-Vezinet F; Masquelier B; Costagliola D;
    J Antimicrob Chemother; 2010 Dec; 65(12):2620-7. PubMed ID: 20965891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary antiretroviral drug resistance among patients diagnosed with HIV infection in Gran Canaria (Spain) between 2002 and 2005].
    Sánchez Oñoro M; López MJ; Santana MA; Andés JM; Campelo FA
    Enferm Infecc Microbiol Clin; 2007; 25(7):437-40. PubMed ID: 17692211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmitted multidrug resistant HIV-1: new and investigational therapeutic approaches.
    Shet A; Markowitz M
    Curr Opin Investig Drugs; 2006 Aug; 7(8):709-20. PubMed ID: 16955682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W
    J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.